<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Disorders affecting the spinal cord
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Disorders affecting the spinal cord
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Disorders affecting the spinal cord
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Andrew Eisen, MD, FRCPC
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael J Aminoff, MD, DSc
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Janet L Wilterdink, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Feb 04, 2021.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pathologies that affect the spinal cord are diverse. In addition to trauma, common etiologies of myelopathy include autoimmune, infectious, neoplastic, vascular, and hereditary-degenerative diseases. The relative incidence of each of these entities depends in large part upon the clinical setting. In a regional neuroscience center in the United Kingdom, the most common cause of spastic paraparesis or quadriparesis among 585 patients was cervical spondylotic myelopathy (24 percent), followed by tumor (16 percent), multiple sclerosis (MS; 18 percent), and motor neuron disease (4 percent) [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         This topic will review some of the more common and important causes of nontraumatic spinal cord dysfunction. Clinical features of the more common of these disorders are summarized in the table  (
         <a class="graphic graphic_table graphicRef50336" href="/z/d/graphic/50336.html" rel="external">
          table 1
         </a>
         ). Traumatic spinal cord injury and the anatomy and clinical localization of spinal cord disease are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4819.html" rel="external">
          "Acute traumatic spinal cord injury"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5110.html" rel="external">
          "Anatomy and localization of spinal cord disorders"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          INFLAMMATORY DISEASES
         </span>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Transverse myelitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transverse myelitis (TM) is a segmental spinal cord injury caused by acute inflammation [
         <a href="#rid2">
          2-4
         </a>
         ]. TM is uncommon, with an approximate incidence of between one to five cases per million population annually [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         Most cases of TM are idiopathic and presumably result from an autoimmune process; up to half of these patients have a preceding infection [
         <a href="#rid6">
          6-8
         </a>
         ]. TM can also occur in multiple sclerosis (MS) and can be the presenting demyelinating event [
         <a href="#rid9">
          9
         </a>
         ]. Neuromyelitis optica or Devic disease is a disorder related to MS, in which demyelinating events are limited to the optic nerve and spinal cord. (See
         <a class="medical medical_review" href="/z/d/html/14089.html" rel="external">
          "Neuromyelitis optica spectrum disorder (NMOSD): Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
         TM is also associated with connective tissue diseases, including:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Systemic lupus erythematosus [
         <a href="#rid6">
          6,10,11
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mixed connective tissue disease [
         <a href="#rid12">
          12
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sjögren's syndrome [
         <a href="#rid6">
          6,13,14
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Scleroderma [
         <a href="#rid15">
          15
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Antiphospholipid antibody syndrome [
         <a href="#rid6">
          6
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ankylosing spondylitis [
         <a href="#rid16">
          16
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rheumatoid arthritis [
         <a href="#rid17">
          17
         </a>
         ]
        </p>
        <p>
        </p>
        <p>
         The inflammation of TM is generally restricted to one or two segments, usually in the thoracic cord. Symptoms typically develop rapidly over several hours; approximately 37 percent of patients worsen maximally within 24 hours [
         <a href="#rid18">
          18
         </a>
         ]. Occasionally patients worsen more slowly, over several weeks. Typically the inflammation is bilateral, producing weakness and multimodality sensory disturbance below the level of the lesion [
         <a href="#rid5">
          5,7
         </a>
         ]. Unilateral syndromes (eg, Brown-Séquard) have been described as well. Almost all patients develop leg weakness of varying severity. Arm weakness also occurs if the lesion is in the cervical cord. In addition to diminished sensation, pain and tingling are common and frequently include a tight banding or girdle-like sensation around the trunk, which may be very sensitive to touch. Back and radicular pain are also common. Bowel and bladder dysfunction, reflective of autonomic involvement, also occur.
        </p>
        <p>
         Magnetic resonance imaging (MRI) of the involved section of the spinal cord shows gadolinium-enhancing signal abnormality, usually extending over one or more cord segments  (
         <a class="graphic graphic_diagnosticimage graphicRef73197" href="/z/d/graphic/73197.html" rel="external">
          image 1
         </a>
         ) [
         <a href="#rid5">
          5,8,19,20
         </a>
         ]. The cord often appears swollen at these levels. Cerebrospinal fluid (CSF) is abnormal in half of patients, with elevated protein level (usually 100 to 120 mg/100 mL) and moderate lymphocytosis (usually &lt;100/mm
         <sup>
          3
         </sup>
         ). Glucose levels are normal. Oligoclonal bands are usually not present in isolated TM, and when present suggest a higher risk of subsequent MS [
         <a href="#rid5">
          5,21
         </a>
         ]. Other studies can help delineate the underlying cause  (
         <a class="graphic graphic_table graphicRef65585" href="/z/d/graphic/65585.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
         Most patients with idiopathic TM have at least a partial recovery, which usually begins within one to three months [
         <a href="#rid22">
          22
         </a>
         ]. Some degree of persistent disability is common, occurring in approximately 40 percent [
         <a href="#rid8">
          8,22
         </a>
         ]. Significant recovery is unlikely if there is no improvement by three months. A very rapid onset with complete paraplegia and spinal shock have been associated with poorer outcomes [
         <a href="#rid6">
          6,22,23
         </a>
         ]. TM is generally a monophasic illness. However, a small percentage of patients may suffer a recurrence [
         <a href="#rid24">
          24,25
         </a>
         ].
        </p>
        <p>
         While patients are often treated with parenteral corticosteroid therapy, there is limited evidence that this approach alters outcomes [
         <a href="#rid6">
          6,8,22
         </a>
         ]. Patients with TM associated with systemic autoimmune disease may be more likely to receive treatment corticosteroids and other immunosuppressive and immunomodulatory therapies [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
         MS is more likely to develop in those with partial and asymmetric cord involvement versus a complete cord syndrome [
         <a href="#rid27">
          27,28
         </a>
         ]. A finding of demyelinating lesions on brain MRI also identifies those at higher risk for MS [
         <a href="#rid21">
          21
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1688.html" rel="external">
          "Evaluation and diagnosis of multiple sclerosis in adults", section on 'Acute and subacute transverse myelitis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Sarcoidosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The granulomatous inflammation of sarcoidosis can affect the spinal cord and produce an acute or subacute segmental myelopathy [
         <a href="#rid6">
          6,29-31
         </a>
         ]. The lesions can be extramedullary or intramedullary, and can involve the cauda equina as well as the cord. MRI signal abnormalities are not specific; neurosarcoid lesions can appear similar to TM or can resemble a tumor. CSF evaluation usually shows elevated protein and/or pleocytosis. Hilar lymphadenopathy may suggest the diagnosis; however, serum and CSF angiotensin converting enzyme levels are neither sensitive nor specific for neurosarcoidosis. Patients with neurologic sarcoidosis are generally treated with corticosteroids and other immunomodulatory agents and can improve. (See
         <a class="medical medical_review" href="/z/d/html/4834.html" rel="external">
          "Neurologic sarcoidosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Paraneoplastic syndromes
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of distinct paraneoplastic syndromes involving the spinal cord have been described. These rare syndromes include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Motor neuron syndrome – a subacute, progressive, painless, and often asymmetric lower motor neuron weakness, most often associated with lymphoma [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute necrotizing myelopathy – a rapidly ascending syndrome of sensory deficits, sphincter dysfunction, and flaccid or spastic paraplegia or quadriplegia [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Subacute sensory neuronopathy – an inflammatory disorder affecting the dorsal root ganglia, producing progressive loss of sensory modalities, leading to prominent ataxia [
         <a href="#rid34">
          34
         </a>
         ]. This is most often associated with small cell lung cancer and anti-Hu antibodies.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Encephalomyelitis – a diffuse involvement of brain and spinal cord regions, in which cerebral manifestations frequently overshadow the myelopathy. Several syndromes are described.
        </p>
        <p>
        </p>
        <p>
         These are described separately. (See
         <a class="medical medical_review" href="/z/d/html/5190.html" rel="external">
          "Paraneoplastic syndromes affecting spinal cord, peripheral nerve, and muscle"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          INFECTIONS
         </span>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Epidural abscess
         </span>
         <span class="headingEndMark">
          —
         </span>
         Spinal epidural abscess is a rare disease, occurring in only 1 patient per 10,000 admitted to the hospital [
         <a href="#rid35">
          35
         </a>
         ]. The infection can originate via contiguous spread from infections of skin and soft tissues or as a complication of spinal surgery and other invasive procedures, including indwelling epidural catheters. Other cases of epidural abscess arise from a remote site via the bloodstream. Diabetes, alcoholism, and human immunodeficiency virus (HIV) infection are risk factors.
        </p>
        <p>
         The most common pathogen is
         <em>
          Staphylococcus aureus
         </em>
         , which accounts for approximately two-thirds of cases [
         <a href="#rid35">
          35
         </a>
         ]. Damage to the spinal cord can be caused by direct compression of neural elements or arterial blood supply, thrombosis and thrombophlebitis of nearby veins, focal vasculitis, and/or bacterial toxins and mediators of inflammation. The classic clinical triad consists of fever, spinal pain, and neurologic deficits. However, only a few patients have all three components at presentation [
         <a href="#rid36">
          36
         </a>
         ]. The rate of neurologic progression is highly variable.
        </p>
        <p>
         Imaging of the spinal column is imperative on first suspicion of the disorder [
         <a href="#rid36">
          36
         </a>
         ]. Magnetic resonance imaging (MRI) is the preferred test and is highly sensitive for this diagnosis. Blood cultures and/or aspirate of abscess contents are ordered to identify the etiologic organism. Surgical decompression and drainage with systemic antibiotic therapy is the treatment of choice for most patients. Because the preoperative neurologic deficit is an important predictor of final neurologic outcome, early diagnosis and treatment are imperative.
        </p>
        <p>
         This topic is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/1292.html" rel="external">
          "Spinal epidural abscess"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Acute viral myelitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Two distinct syndromes of spinal cord involvement are associated with acute viral disease. In the first, the virus targets the gray matter of the spinal cord, producing acute lower motor neuron disease [
         <a href="#rid37">
          37
         </a>
         ]. These viruses include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Enteroviruses, such as poliovirus, coxsackie virus, and enterovirus 71 [
         <a href="#rid38">
          38
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Flaviviruses, such as West Nile virus and Japanese encephalitis virus [
         <a href="#rid39">
          39-41
         </a>
         ]
        </p>
        <p>
        </p>
        <p>
         Viral invasion of the anterior horn cells occurs as part of an acute viral illness, usually with fever, headache, and meningismus, and produces asymmetrical flaccid weakness with reduced or absent reflexes and few sensory symptoms or signs. MRI often shows hyperintensities in the anterior horns of the spinal cord on T2-weighted imaging [
         <a href="#rid38">
          38,42
         </a>
         ]. Cerebrospinal fluid (CSF) analysis demonstrates a moderate pleocytosis. These features help to distinguish this form of viral myelitis from Guillain-Barré syndrome, which usually produces symmetric deficits, with no MRI abnormalities, and is associated with elevated CSF protein levels without pleocytosis. (See
         <a class="medical medical_review" href="/z/d/html/5137.html" rel="external">
          "Guillain-Barré syndrome in adults: Pathogenesis, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
         Focal or segmental depletion of spinal motor neurons has been described at autopsy, reflecting the observed pattern of neurologic deficits [
         <a href="#rid43">
          43,44
         </a>
         ]. The prognosis for recovery is variable. Treatment is supportive. (See
         <a class="medical medical_review" href="/z/d/html/1273.html" rel="external">
          "Clinical manifestations and diagnosis of West Nile virus infection", section on 'Neuroinvasive disease'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">
          "Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Acute paralysis and brainstem encephalitis'
         </a>
         .)
        </p>
        <p>
         A second form of viral myelitis has clinical and diagnostic test features that are similar to transverse myelitis. Associated viruses include cytomegalovirus, varicella zoster, herpes simplex virus, hepatitis C, and Epstein Barr virus [
         <a href="#rid45">
          45-51
         </a>
         ]. The association between the myelitis and the virus is not always clear. In some cases, these may represent a postinfectious transverse myelitis. In others, a positive polymerase chain reaction (PCR) test in the CSF suggests that the myelitis is directly related to the viral infection. These patients are often treated with antiviral agents and corticosteroids.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          AIDS myelopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         HIV infection produces a vacuolar myelopathy, which is found in up to half of patients with AIDS at autopsy [
         <a href="#rid36">
          36,52
         </a>
         ]. However, clinical manifestations occur when the pathology is advanced, and only approximately one-fourth of patients demonstrating vacuolar myelopathy at autopsy have symptoms during life [
         <a href="#rid53">
          53
         </a>
         ]. AIDS myelopathy most often occurs in late stages of AIDS; most patients die within six months of developing symptoms of myelopathy. HIV-related dementia is present in more than half of patients and, with other disease complications, may obscure the myelopathy.
        </p>
        <p>
         In typical cases, a slowly progressive spastic paraparesis is accompanied by loss of vibration and position sense and urinary frequency, urgency, and incontinence [
         <a href="#rid28">
          28
         </a>
         ]. Upper-extremity function is usually normal. MRI of the spine is usually normal. CSF examination may show nonspecific abnormalities, such as protein elevation. Abnormal sensory evoked potentials may precede clinical symptoms of myelopathy. Aggressive antiretroviral therapy can lead to improvement of symptoms [
         <a href="#rid54">
          54
         </a>
         ]. In one case series, the use of intravenous immunoglobulin appeared to be associated with neurologic improvement [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
         The pathogenesis of vacuolar myelopathy is unknown but may be related to abnormal transmethylation mechanisms induced by the virus and/or cytokines. In one series of 16 patients, there was no correlation between the viral load in the CSF and the presence or severity of myelopathy [
         <a href="#rid56">
          56
         </a>
         ]. Pathologic descriptions include demyelination of the dorsal columns and the dorsal half of the lateral columns, with prominent vacuoles within the myelin sheaths. This pathologic appearance is similar to the changes seen in the subacute combined degeneration of the cord.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          HTLV-I myelopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Human T-lymphotropic virus type I (HTLV-I) causes a progressive neurologic disease, which is called either HTLV-1-associated myelopathy (HAM) or tropical spastic paraparesis (TSP) [
         <a href="#rid57">
          57,58
         </a>
         ]. This disorder is endemic in southern Japan, the Caribbean, South America, the Melanesian islands, Papua New Guinea, the Middle East, and central and southern Africa, with seroprevalences as high as 30 percent in southern Japan [
         <a href="#rid59">
          59-61
         </a>
         ]. By contrast, it is quite rare in the United States and Europe. It is more common in women than men.
        </p>
        <p>
         Primarily involving the thoracic cord, HAM/TSP is characterized by a slowly progressive spastic paraparesis and urinary disturbance. Pathologic studies demonstrate inflammation of the lateral corticospinal, spinocerebellar, and spinothalamic tracts, with relative sparing of the posterior columns [
         <a href="#rid62">
          62
         </a>
         ]. HAM/TSP has also been associated with other nervous system pathology that results in less frequent symptoms, suggesting cerebral, cerebellar, cranial nerve, and peripheral nerve involvement [
         <a href="#rid57">
          57,61
         </a>
         ].
        </p>
        <p>
         MRI of the spinal cord may show spinal atrophy, particularly of the thoracic cord [
         <a href="#rid58">
          58,63
         </a>
         ]. A brain MRI often shows subcortical, periventricular white matter lesions. CSF examination reveals a mild lymphocytosis and/or elevated protein concentration in some patients. Anti-HTLV-I antibodies are detected in the CSF with a high CSF:serum ratio. The virus can be cultured from CSF lymphocytes and proviral DNA detected by PCR.
        </p>
        <p>
         In general, neurologic deficits continue to progress slowly; steroids and other immunomodulatory treatment may slow progression, but this is not proven. This topic is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/8317.html" rel="external">
          "Human T-lymphotropic virus type I: Disease associations, diagnosis, and treatment"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8316.html" rel="external">
          "Human T-lymphotropic virus type I: Virology, pathogenesis, and epidemiology"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Syphilis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tabes dorsalis is a form of tertiary neurosyphilis in which the dorsal or posterior columns of the spinal cord are primarily affected. Patients present with a sensory ataxia and lancinating pains reflecting dorsal column and dorsal nerve root involvement. CSF examination may be normal or demonstrate elevated protein level, lymphocytosis, and/or a reactive Venereal Disease Research Laboratory (VDRL). Antibiotic treatment may reverse symptoms. (See
         <a class="medical medical_review" href="/z/d/html/7599.html" rel="external">
          "Neurosyphilis", section on 'Tabes dorsalis'
         </a>
         .)
        </p>
        <p>
         Syphilitic meningomyelitis and meningovascular myelitis represent an earlier form of syphilis infection in which focal inflammation of the meninges secondarily affects the adjacent spinal cord and/or the anterior spinal artery. In the former situation, a subacute progressive myelopathy develops [
         <a href="#rid64">
          64
         </a>
         ]. In the latter, the clinical presentation may be one of a spinal cord infarction. (See
         <a class="medical medical_review" href="/z/d/html/7599.html" rel="external">
          "Neurosyphilis", section on 'Meningovascular syphilis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1125.html" rel="external">
          "Spinal cord infarction: Epidemiology and etiologies"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Tuberculosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tuberculosis can produce a myelopathy by different mechanisms. Infection of the vertebral body leads to tuberculous spondylitis or Pott's disease, which can lead to secondary cord compression. These patients present with back pain over the affected vertebra, low-grade fever, and weight loss, followed by a secondary compressive myelopathy [
         <a href="#rid65">
          65
         </a>
         ]. Tuberculomas within the intramedullary, intradural, and extradural space can also produce myelopathy [
         <a href="#rid66">
          66,67
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7658.html" rel="external">
          "Bone and joint tuberculosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8009.html" rel="external">
          "Central nervous system tuberculosis: An overview"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Parasite infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         The parasites
         <em>
          Schistosoma mansoni
         </em>
         and
         <em>
          Schistosoma haematobium
         </em>
         typically infect the spinal cord, producing rapidly progressing symptoms of TM, including lower limb pain, weakness, and bowel and bladder dysfunction [
         <a href="#rid68">
          68,69
         </a>
         ]. The lower thoracic region of the spinal cord is most frequently involved, followed by the lumbar and sacral regions. Spinal cord involvement can lead to permanent paralysis. CSF evaluation reveals pleocytosis and elevated protein; eosinophilia occurs in almost half of patients. MRI demonstrates signal change and swelling within the cord. Most patients are treated with glucocorticoids and
         <a class="drug drug_general" data-topicid="9805" href="/z/d/drug information/9805.html" rel="external">
          praziquantel
         </a>
         and achieve at least partial recovery. (See
         <a class="medical medical_review" href="/z/d/html/5717.html" rel="external">
          "Schistosomiasis: Epidemiology and clinical manifestations"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5705.html" rel="external">
          "Schistosomiasis: Treatment and prevention"
         </a>
         .)
        </p>
        <p>
         Cysticercosis has been reported to cause a cyst within the spinal cord [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Others
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bacterial meningitis may be complicated by a myelopathy due to formation of an epidural abscess, myelitis, or vasculitic infarction [
         <a href="#rid65">
          65,71,72
         </a>
         ].
        </p>
        <p>
         Lyme disease rarely affects the spinal cord. However, cases have been described in which clinical and MRI features resembling acute TM have been attributed to Lyme disease [
         <a href="#rid73">
          73,74
         </a>
         ]. CSF in these cases typically demonstrates a lymphocytic pleocytosis and elevated protein. (See
         <a class="medical medical_review" href="/z/d/html/7913.html" rel="external">
          "Clinical manifestations of Lyme disease in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          VASCULAR DISEASE
         </span>
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Spinal cord infarction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infarction of the spinal cord is rare compared with cerebral infarction. Spinal cord infarction is most frequently caused by surgical procedures and pathologies affecting the aorta [
         <a href="#rid75">
          75
         </a>
         ]. Other causes of spinal cord infarction are diverse and include any etiology that also produces brain infarction (eg, atherosclerosis, embolism, and hypercoagulable and vasculitic disorders) [
         <a href="#rid75">
          75-78
         </a>
         ]. Spinal cord infarction can also occur in the setting of severe systemic hypotension or cardiac arrest.
        </p>
        <p>
         Symptoms are consistent with the functional loss within the anterior spinal artery territory and include paralysis, loss of bladder function, and loss of pain and temperature sensation below the level of the lesion. Position and vibratory sensation are spared. The onset of symptoms is sudden and is frequently associated with back pain.
        </p>
        <p>
         Magnetic resonance imaging (MRI) will demonstrate a T2 signal change consistent with cord ischemia, but may be normal in the first 24 hours [
         <a href="#rid79">
          79,80
         </a>
         ]. Diffusion-weighted imaging (DWI) is more sensitive [
         <a href="#rid81">
          81-83
         </a>
         ]. Cerebrospinal fluid (CSF) protein level may be elevated, but pleocytosis is rare.
        </p>
        <p>
         Less than half of patients show substantial motor recovery following spinal cord infarction [
         <a href="#rid75">
          75,84
         </a>
         ]. Treatment is generally supportive and focused on the underlying aortic pathology and/or secondary stroke prevention.
        </p>
        <p>
         Spinal cord infarction is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/1125.html" rel="external">
          "Spinal cord infarction: Epidemiology and etiologies"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1115.html" rel="external">
          "Spinal cord infarction: Treatment and prognosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Vascular malformations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vascular malformations of the spinal cord are classified into types according to their location and vascular pathology [
         <a href="#rid85">
          85,86
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dural arteriovenous fistula is the most common type, making up approximately 70 percent of all lesions [
         <a href="#rid87">
          87
         </a>
         ]. These exist on the dural surface and drain intradurally by retrograde flow through a single medullary vein to the anterior or posterior median vein, resulting in engorgement of the coronal venous plexus. They usually present after the fifth decade of life and are more common in men. The most common clinical presentation is that of progressive, often stepwise myeloradiculopathy, probably related to venous hypertension. Some patients present with neurogenic claudication [
         <a href="#rid88">
          88
         </a>
         ]. Symptoms may initially fluctuate, but eventually a permanent and progressive paraparesis with sensory disturbances and sphincter dysfunction occurs.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         MRI with contrast-enhanced magnetic resonance angiography (MRA) can identify a dural arteriovenous fistula but has imperfect sensitivity [
         <a href="#rid88">
          88-93
         </a>
         ]. The most common finding is a nonspecific hyperintense signal lesion on T2-weighted images. The more specific findings of intradural flow voids on T2-weighted images, and/or serpentine enhancement on MRA and T1 images, are seen in 85 to 100 percent or more of patients. If MRI/MRA cannot be performed, myelography with supine and prone images may demonstrate the serpentine vessels within the intradural space. When positive, MRA and/or myelography can help guide the performance of the spinal angiogram, which remains the gold-standard test, and is required prior to therapeutic intervention. Spinal angiography can be a difficult diagnostic procedure in this setting, often requiring multiple injections of segmental arteries in order to identify the feeding artery, especially when MRA does not provide specific guiding information. However, at least one observational study found that in experienced hands, the complication rate is low (1 to 2 percent) and did not (at least in this series) involve any neurologic morbidity [
         <a href="#rid94">
          94
         </a>
         ]. Occlusion of the fistula by surgery or endovascular embolization can be helpful in stabilizing, even ameliorating, the neurologic deficits [
         <a href="#rid92">
          92,95-97
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intramedullary spinal arteriovenous malformations (AVMs) [
         <a href="#rid98">
          98,99
         </a>
         ] are supplied by medullary arteries and drain through medullary veins. The mean age at clinical presentation is the mid-20s, but close to 20 percent of the lesions are diagnosed in children under 16 years of age [
         <a href="#rid98">
          98
         </a>
         ]. A myelopathy is produced by the mass effect of the lesion or by ischemia or hemorrhage into the cord. Some patients present instead with subarachnoid hemorrhage. MRI is sensitive for intramedullary AVM, showing a cluster of low-intensity signal foci [
         <a href="#rid86">
          86
         </a>
         ]. Contrast-enhanced MRA also helps localize the nidus and identify arterial supply and venous drainage. These lesions are treated by endovascular occlusion, surgical resection, or both [
         <a href="#rid100">
          100
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Spinal epidural hematoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Spinal epidural hematoma can complicate procedures that involve a spinal dural puncture, usually in patients with thrombocytopenia or bleeding diathesis, including anticoagulant therapy [
         <a href="#rid101">
          101
         </a>
         ]. Rarely, this occurs spontaneously; a predisposition to bleeding is a risk factor in these patients as well [
         <a href="#rid102">
          102-104
         </a>
         ]. Some occur in the setting of minor trauma.
        </p>
        <p>
         Patients typically present with local and/or radicular pain, followed by loss of sensory, motor, and bladder and bowel function [
         <a href="#rid102">
          102-104
         </a>
         ]. The source of bleeding is usually venous rather than arterial, and symptoms typically present over days, although more abrupt presentations are also described.
        </p>
        <p>
         MRI is a sensitive imaging modality for these lesions [
         <a href="#rid103">
          103,105
         </a>
         ]. MRI findings vary according to the age of the clot. In the first 24 hours the hematoma is usually isointense on T1- and hyperintense on T2-weighted images; after 24 hours, it becomes mostly hyperintense on T1 and on T2.
        </p>
        <p>
         The appropriate treatment for patients with significant and/or progressing neurologic deficits is prompt surgical intervention, usually a laminectomy, and evacuation of the blood. Timely decompression of the hematoma is essential to avoid permanent loss of neurologic function [
         <a href="#rid106">
          106,107
         </a>
         ]. Many individuals with minor, stable neurologic deficits can be managed by observation and have a good prognosis for complete recovery [
         <a href="#rid102">
          102,104
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h1">
          TOXIC, METABOLIC DISORDERS
         </span>
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h2">
          Subacute combined degeneration
         </span>
         <span class="headingEndMark">
          —
         </span>
         Deficiency in
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         (cobalamin) leads to degeneration of the dorsal and lateral white matter of the spinal cord, producing a slowly progressive weakness, sensory ataxia, and paresthesias, and ultimately spasticity, paraplegia, and incontinence [
         <a href="#rid108">
          108
         </a>
         ]. Not all patients with neurologic abnormalities will have anemia or macrocytosis [
         <a href="#rid109">
          109
         </a>
         ]. Supplemental treatment with vitamin B12 can stop progression and will produce neurologic improvement in most patients [
         <a href="#rid110">
          110
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7155.html" rel="external">
          "Clinical manifestations and diagnosis of vitamin B12 and folate deficiency"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7155.html" rel="external">
          "Clinical manifestations and diagnosis of vitamin B12 and folate deficiency", section on 'Clinical presentation'
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">
          Nitrous oxide
         </a>
         abuse can also lead to subacute combined degeneration, by inactivation of
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         [
         <a href="#rid111">
          111-114
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6502.html" rel="external">
          "Inhalant misuse in children and adolescents"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20816123">
         <span class="h2">
          Copper deficiency myeloneuropathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         A syndrome similar to the subacute combined degeneration of
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         deficiency can occur with acquired copper deficiency, which may be the result of gastrointestinal surgery, excessive zinc ingestion (eg, overuse of denture cream), and other causes [
         <a href="#rid115">
          115-117
         </a>
         ]. Most patients also have hematologic abnormalities. Treatment can prevent progression, but patients with significant neurologic deficits at presentation often remain disabled. (See
         <a class="medical medical_review" href="/z/d/html/16517.html" rel="external">
          "Copper deficiency myeloneuropathy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h2">
          Radiation myelopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Myelopathy is a serious complication of radiation therapy to the spinal cord [
         <a href="#rid118">
          118,119
         </a>
         ]. White matter tracts in the lateral aspects of the cord are preferentially affected [
         <a href="#rid120">
          120,121
         </a>
         ]. Two distinct clinical presentations are described:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A transient myelopathy occurring two to six months after irradiation is usually mild and resolves spontaneously over several months.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A late progressive myelopathy begins 6 to 12 months after irradiation. This begins insidiously and generally progresses inexorably, although some cases stabilize. Magnetic resonance imaging (MRI) is important to exclude other etiologies and will typically show hyperintensity on T2 and fluid-attenuated inversion recovery (FLAIR) sequences. A high radiation dose is a risk factor [
         <a href="#rid122">
          122
         </a>
         ]. Fractionation size, concomitant chemotherapy, and other comorbidities may play a role. There is no effective treatment.
        </p>
        <p>
        </p>
        <p>
         This topic is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7066.html" rel="external">
          "Complications of spinal cord irradiation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5584764">
         <span class="h2">
          Intrathecal chemotherapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Myelopathy can occur as a complication of intrathecal chemotherapy, particularly
         <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">
          methotrexate
         </a>
         and
         <a class="drug drug_general" data-topicid="9314" href="/z/d/drug information/9314.html" rel="external">
          cytarabine
         </a>
         [
         <a href="#rid123">
          123-126
         </a>
         ]. This appears to be an idiosyncratic reaction, as a wide range of dose and timing with respect to the administration of intrathecal chemotherapy has been reported. The clinical syndrome resembles subacute combined degeneration, and MRI frequently shows abnormalities in the dorsal columns on T2-weighted images. (See
         <a class="medical medical_review" href="/z/d/html/2836.html" rel="external">
          "Overview of neurologic complications of conventional non-platinum cancer chemotherapy", section on 'Transverse myelopathy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2836.html" rel="external">
          "Overview of neurologic complications of conventional non-platinum cancer chemotherapy", section on 'Intrathecal cytarabine'
         </a>
         .)
        </p>
        <p>
         Individual cases of myelopathy with treatment with antitumor necrosis factors as well as intravenous administration of
         <a class="drug drug_general" data-topicid="9271" href="/z/d/drug information/9271.html" rel="external">
          cisplatin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9272" href="/z/d/drug information/9272.html" rel="external">
          cladribine
         </a>
         , and
         <a class="drug drug_general" data-topicid="9206" href="/z/d/drug information/9206.html" rel="external">
          carmustine
         </a>
         have also been reported, but these appear to be rare [
         <a href="#rid123">
          123,127
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h2">
          Electrical injury
         </span>
         <span class="headingEndMark">
          —
         </span>
         High-voltage electrical injury can be associated with a variety of neurologic complications, including spinal cord injury. (See
         <a class="medical medical_review" href="/z/d/html/175.html" rel="external">
          "Electrical injuries and lightning strikes: Evaluation and management"
         </a>
         .)
        </p>
        <p>
         Different syndromes have been described:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A transient flaccid paralysis, called keraunoparalysis, is apparent immediately following the injury, affects the legs more than the arms, and typically resolves within the first 24 hours [
         <a href="#rid128">
          128,129
         </a>
         ]. This is most often described in association with lightning strike. Peripheral vasoconstriction and sensory disturbances are commonly associated. The pathophysiology is uncertain.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other patients develop a more enduring and sometimes permanent spinal cord injury after electrical injury [
         <a href="#rid130">
          130-133
         </a>
         ]. In this situation, clinical signs of myelopathy may be present at the time of injury, or may develop after several days or weeks. Motor deficits are more prominent than sensory findings. Bladder and other sphincter dysfunction can occur. Spine MRI is typically normal. The clinical course and prognosis are not well characterized. Direct heat and electrical injury to neural elements, as well as a delayed microvascular disease, are proposed mechanisms.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h2">
          Hepatic myelopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Progressive myelopathy is a rare neurologic complication of chronic liver disease with portal hypertension [
         <a href="#rid134">
          134-137
         </a>
         ]. The myelopathy is predominantly or entirely motor in manifestation, reflected as a spastic paraparesis that progresses over months to paraplegia [
         <a href="#rid138">
          138
         </a>
         ]. Deficits are limited to the lower extremities; sensory and bladder function is often unaffected. MRI and cerebrospinal fluid (CSF) studies are normal. Neuropathologic studies have demonstrated demyelination of the lateral corticospinal tracts with various degrees of axonal loss [
         <a href="#rid136">
          136
         </a>
         ].
        </p>
        <p>
         In contrast to hepatic encephalopathy, ammonia-lowering treatments have little or no effect on the myelopathy, but patients with early manifestations of spinal cord impairment may improve with liver transplantation [
         <a href="#rid138">
          138
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h2">
          Decompression sickness myelopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Impairment of spinal cord function can be a manifestation of decompression sickness, a complication of deep sea diving [
         <a href="#rid139">
          139-143
         </a>
         ]. Symptoms usually develop during or immediately after ascent but may be delayed for several hours or a few days. The thoracic cord is most commonly involved, producing paraparesis of varying severity and a sensory level in the mid or low thoracic region. Lesions at higher spinal cord levels producing quadriplegia have also been described [
         <a href="#rid142">
          142
         </a>
         ].
        </p>
        <p>
         Early therapeutic recompression frequently reverses symptoms and signs [
         <a href="#rid140">
          140
         </a>
         ]. Residual corticospinal and minor sensory signs may remain for months or indefinitely [
         <a href="#rid143">
          143
         </a>
         ]. Both MRI and pathologic studies have shown multifocal white matter degeneration in the posterior and lateral columns of the spinal cord with secondary ascending and descending tract degeneration [
         <a href="#rid137">
          137,142
         </a>
         ]. Gaseous occlusion of venous plexi within the spinal cord is one postulated mechanism of injury. (See
         <a class="medical medical_review" href="/z/d/html/177.html" rel="external">
          "Complications of SCUBA diving", section on 'Decompression sickness'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h2">
          Lathyrism and konzo
         </span>
         <span class="headingEndMark">
          —
         </span>
         Two disorders of spastic paraparesis have been described, which occur in association with increased dietary intake of food plants with neurotoxic potential, as occurs in certain geographic regions during times of famine [
         <a href="#rid144">
          144,145
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neurolathyrism is associated with prolonged consumption of the grass or chickling pea (
         <em>
          Lathyrus sativus
         </em>
         ) [
         <a href="#rid146">
          146
         </a>
         ]. Exposed persons develop a slowly developing spastic paraparesis with cramps, paresthesias, and numbness, accompanied by bladder symptoms and impotence. Some patients have tremors and other involuntary movements in their arms. Pathologic studies have demonstrated a loss of myelinated fibers in the corticospinal and spinocerebellar tracts. The toxin appears to be the neuroexcitatory amino acid, beta-N-oxalylaminoalanine. There is no treatment.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Konzo, a disorder characterized by acute spastic paraparesis or quadriparesis, is linked to high exposure to cyanogenic compounds in diets containing insufficiently processed bitter cassava (
         <em>
          Manihot esculenta
         </em>
         ) [
         <a href="#rid147">
          147,148
         </a>
         ]. This disorder is less well characterized than lathyrism, and it may reflect a disorder of intracranial rather than intraspinal motor pathways.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h1">
          NEOPLASMS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Both benign and malignant tumors can produce a myelopathy as a result of external compression or intramedullary growth.
        </p>
        <p>
         The most common syndrome is that of extradural spinal cord compression, as produced by metastases to the extradural space. Patients present with a progressive weakness below the level of the lesion with accompanying sensory loss and bladder dysfunction [
         <a href="#rid149">
          149
         </a>
         ]. Pain at the site of involvement is typical. Progression to paraplegia can occur abruptly, as a result of vascular compression. Because the prognosis for neurologic recovery depends on the severity of the deficit at the time of intervention (high-dose corticosteroids with radiation therapy and/or surgical decompression), diagnostic evaluation (with gadolinium-enhanced spinal magnetic resonance imaging [MRI]) must proceed promptly when this diagnosis is considered [
         <a href="#rid150">
          150
         </a>
         ]. This topic is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2819.html" rel="external">
          "Clinical features and diagnosis of neoplastic epidural spinal cord compression"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2820.html" rel="external">
          "Treatment and prognosis of neoplastic epidural spinal cord compression"
         </a>
         .)
        </p>
        <p>
         Intramedullary spinal cord tumors are typically primary central nervous system tumors (ependymoma, astrocytoma); metastases are less likely [
         <a href="#rid151">
          151,152
         </a>
         ]. These produce a progressive myelopathy, often with central cord features. MRI with gadolinium will show the tumor [
         <a href="#rid153">
          153
         </a>
         ]; biopsy with histologic examination is usually required for diagnosis. Because of their intramedullary location, management of these lesions is difficult. (See
         <a class="medical medical_review" href="/z/d/html/5227.html" rel="external">
          "Spinal cord tumors"
         </a>
         .)
        </p>
        <p>
         Myelopathy can also occur as a complication of radiation therapy (see
         <a class="local">
          'Radiation myelopathy'
         </a>
         above); as a complication of intrathecal chemotherapy; particularly
         <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">
          methotrexate
         </a>
         and
         <a class="drug drug_general" data-topicid="9314" href="/z/d/drug information/9314.html" rel="external">
          cytarabine
         </a>
         (see
         <a class="medical medical_review" href="/z/d/html/2836.html" rel="external">
          "Overview of neurologic complications of conventional non-platinum cancer chemotherapy", section on 'Transverse myelopathy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2836.html" rel="external">
          "Overview of neurologic complications of conventional non-platinum cancer chemotherapy", section on 'Intrathecal cytarabine'
         </a>
         ); and as a paraneoplastic syndrome. (See
         <a class="local">
          'Paraneoplastic syndromes'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5190.html" rel="external">
          "Paraneoplastic syndromes affecting spinal cord, peripheral nerve, and muscle", section on 'Myelopathy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h1">
          INHERITED AND DEGENERATIVE CONDITIONS
         </span>
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h2">
          Amyotrophic lateral sclerosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder that produces progressive weakness, usually with mixed upper and motor neuron signs [
         <a href="#rid154">
          154,155
         </a>
         ]. Symptoms begin insidiously in older adults (usually &gt;60 years) and progress inexorably. In typical patients, there is asymmetric limb weakness with a mixture of upper and lower motor neuron features. Sensory and sphincter disturbances are usually absent. Magnetic resonance imaging (MRI) is normal. Electromyography typically shows denervation in clinically affected muscles. (See
         <a class="medical medical_review" href="/z/d/html/5136.html" rel="external">
          "Clinical features of amyotrophic lateral sclerosis and other forms of motor neuron disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5138.html" rel="external">
          "Diagnosis of amyotrophic lateral sclerosis and other forms of motor neuron disease"
         </a>
         .)
        </p>
        <p>
         Unusual variants of ALS with atypical symptoms can present a diagnostic challenge. Primary lateral sclerosis is a rare variant of ALS with primarily upper motor neuron features [
         <a href="#rid156">
          156
         </a>
         ]. Muscle stiffness leading to overt and progressive spasticity without associated muscle weakness or atrophy typifies the disorder. In approximately two-thirds of patients, there is an ascending pattern with spasticity spreading in a rather stereotyped fashion from the legs to the arms and finally to involve the bulbar musculature [
         <a href="#rid157">
          157
         </a>
         ]. Without positive test findings, this is a diagnosis of exclusion. There is no treatment. (See
         <a class="medical medical_review" href="/z/d/html/5136.html" rel="external">
          "Clinical features of amyotrophic lateral sclerosis and other forms of motor neuron disease", section on 'Primary lateral sclerosis'
         </a>
         .)
        </p>
        <p>
         One familial form of ALS, the recessively inherited D90A mutation, can also present with atypical features, including a long preparetic phase of lower extremity discomfort, followed by a slowly ascending asymmetric paresis that is often accompanied by bladder symptoms [
         <a href="#rid158">
          158-161
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5176.html" rel="external">
          "Familial amyotrophic lateral sclerosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H29">
         <span class="h2">
          Hereditary spastic paraplegias
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hereditary spastic paraplegia (HSP) is a large group of inherited neurologic disorders, in which the prominent feature is a progressive spastic paraparesis [
         <a href="#rid162">
          162
         </a>
         ]. HSP is classified according to the mode of inheritance, the genetic locus when known, and whether the spastic paraplegia syndrome occurs alone or is accompanied by additional neurologic or systemic abnormalities ("pure" versus "complicated") [
         <a href="#rid163">
          163-167
         </a>
         ]. There have been no recent epidemiologic studies, but previously the incidence has been reported to be between 1 in 10,000 and 1 in 100,000.
        </p>
        <p>
         Genetically diverse, with at least 28 genetic loci for HSP identified, the final common pathway for these disorders is a degeneration of the corticospinal tracts [
         <a href="#rid163">
          163
         </a>
         ]. Inheritance is usually autosomal dominant, but recessive and X-linked variants (eg, Pelizaeus-Merzbacher disease) are known.
        </p>
        <p>
         The typical patient with pure HSP will have a slowly progressive spastic paraparesis [
         <a href="#rid163">
          163
         </a>
         ]. The age of onset can vary from infancy to the eighth decade. The first symptoms are often gait disturbance or urinary urgency. Examination reveals spasticity, hyperreflexia, extensor plantar responses, and impaired vibration and/or joint position sense. Weakness may be demonstrated but is rarely the major cause of disability. Upper limb involvement is generally limited to hyperreflexia.
        </p>
        <p>
         HSP is a clinical diagnosis, based in large part on the family history [
         <a href="#rid163">
          163
         </a>
         ]. MRI may be normal or may show atrophy in the spinal cord. Thinning of the corpus callosum on brain MRI is seen in half of patients with the autosomal recessive form of HSP [
         <a href="#rid168">
          168
         </a>
         ]. Otherwise, the diagnosis is based on careful exclusion of other etiologies. Treatment for HSP is limited to symptomatic management [
         <a href="#rid163">
          163
         </a>
         ].
        </p>
        <p>
         HSP is discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/14152.html" rel="external">
          "Hereditary spastic paraplegia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H30">
         <span class="h2">
          Adrenoleukodystrophy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Adrenomyeloneuropathy, a variant of adrenoleukodystrophy, an X-linked recessive disorder, is characterized by a slowly progressive spastic paraparesis and mild polyneuropathy [
         <a href="#rid169">
          169,170
         </a>
         ]. As opposed to the more common and severe phenotype of adrenoleukodystrophy, adrenomyeloneuropathy generally presents in adult men or in female carriers of the mutation. Sensory and sphincter disturbances are typically absent. There may be mild adrenal insufficiency. MRI is typically normal. In the absence of a family history, the finding of a neuropathy on electrophysiologic testing may be a clue to the disorder. The diagnosis is made by the finding of increased very long chain fatty acids in plasma, red blood cells, or cultured skin fibroblasts. (See
         <a class="medical medical_review" href="/z/d/html/6200.html" rel="external">
          "Clinical features, evaluation, and diagnosis of X-linked adrenoleukodystrophy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H31">
         <span class="h2">
          Friedreich ataxia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Friedreich ataxia is an autosomal recessive degenerative disorder of uncertain pathogenesis that typically presents in adolescence [
         <a href="#rid171">
          171
         </a>
         ]. The neuropathologic changes in Friedreich ataxia include degeneration of the posterior columns and the spinocerebellar tracts of the spinal cord and loss of the larger sensory cells of the dorsal root ganglia. These findings correspond to the clinical manifestations of progressive ataxia of all four limbs and gait, weakness, absent reflexes with extensor plantar responses, loss of position and vibration sense, and sparing of pain and temperature. Cardiomyopathy and diabetes mellitus are part of the syndrome. Patients with late-onset disease are more likely to have retained reflexes, spasticity, and no cardiomyopathy [
         <a href="#rid172">
          172
         </a>
         ]. MRI may show atrophy of the cervical cord. Disease severity and rate of progression are highly variable. There is no treatment. This topic is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6224.html" rel="external">
          "Friedreich ataxia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H32">
         <span class="h1">
          OTHERS
         </span>
        </p>
        <p class="headingAnchor" id="H33">
         <span class="h2">
          Syringomyelia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Syringomyelia is a fluid-filled, gliosis-lined cavity within the spinal cord. Most lesions are between C2 and T9; however, they can descend further down or extend upward into the brainstem (syringobulbia). A syrinx can represent a focal dilation of the central canal, or it may lie separately, within the spinal cord parenchyma [
         <a href="#rid173">
          173
         </a>
         ].
        </p>
        <p>
         Syringomyelia most commonly occurs in the setting of the Chiari malformation type I [
         <a href="#rid174">
          174
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13507.html" rel="external">
          "Chiari malformations"
         </a>
         .)
        </p>
        <p>
         Other causes of syringomyelia are [
         <a href="#rid173">
          173-177
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other congenital malformations (eg, Klippel-Feil syndrome, and tethered spinal cord) (see
         <a class="medical medical_review" href="/z/d/html/6433.html" rel="external">
          "Approach to neck stiffness in children", section on 'Congenital'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postinfectious
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postinflammatory (transverse myelitis and multiple sclerosis)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Spinal neoplasms (especially ependymoma and hemangioblastoma) (see
         <a class="medical medical_review" href="/z/d/html/5227.html" rel="external">
          "Spinal cord tumors"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Post-traumatic (see
         <a class="medical medical_review" href="/z/d/html/4839.html" rel="external">
          "Chronic complications of spinal cord injury and disease", section on 'Syringomyelia'
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         A syrinx can be asymptomatic and discovered incidentally on spinal cord imaging. Other patients present with progressive central cord deficits that can include a prominent central pain syndrome in a segmental distribution [
         <a href="#rid178">
          178
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5110.html" rel="external">
          "Anatomy and localization of spinal cord disorders"
         </a>
         .)
        </p>
        <p>
         Magnetic resonance imaging (MRI) will typically identify the intramedullary cavity; gadolinium administration will increase the sensitivity of finding an associated tumor. Surgical decompression with fenestration and/or shunt placement is recommended for patients with neurologic deterioration or intractable central pain [
         <a href="#rid176">
          176-178
         </a>
         ]. Neurologic deficits usually stabilize after intervention and sometimes improve.
        </p>
        <p class="headingAnchor" id="H34">
         <span class="h2">
          Cervical spondylotic myelopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         In many case series, cervical spondylotic myelopathy is the most common cause of myelopathy, particularly in older adults [
         <a href="#rid1">
          1
         </a>
         ]. Degenerative changes in the vertebral bodies, discs, and connecting ligaments encroach on the cervical canal, producing a progressive myelopathy [
         <a href="#rid179">
          179
         </a>
         ]. Symptoms begin insidiously, usually with a spastic gait. Sensory loss, muscle weakness, and atrophy in the hands also cause functional impairment over time. Some patients may develop or present with an acute myelopathy characterized by a central cord syndrome, often in the setting of mild neck trauma.
        </p>
        <p>
         The diagnosis is made by correlating clinical features with evidence of cervical spondylosis and cord compression on MRI [
         <a href="#rid180">
          180
         </a>
         ]. Treatment options include cervical immobilization and surgical decompression. When and if to operate remains controversial. This topic is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4820.html" rel="external">
          "Cervical spondylotic myelopathy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H464259991">
         <span class="h2">
          Ossification of the posterior longitudinal ligament
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ossification of the posterior longitudinal ligament (OPLL) is a condition of abnormal calcification of the posterior longitudinal ligament, usually in the cervical spine [
         <a href="#rid181">
          181-186
         </a>
         ]. Its pathogenesis is not known, but it is more common in Asians than non-Asians (2.4 versus 0.16 percent) and in men (roughly 2:1 male:female ratio). OPLL can be associated with idiopathic skeletal hyperostosis, ankylosing spondylitis, and other spondyloarthropathies, or may occur as an isolated condition. Symptomatic patients typically present in the fifth to sixth decades of life with progressive myelopathic symptoms, but they are also at risk for and can present with acute spinal cord injury [
         <a href="#rid187">
          187
         </a>
         ]. It is diagnosed by characteristic findings on imaging findings (computed tomography [CT] or MRI); significant compressive symptoms typically require surgical decompression. (See
         <a class="medical medical_review" href="/z/d/html/5496.html" rel="external">
          "Diffuse idiopathic skeletal hyperostosis (DISH)", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H464264245">
         <span class="h2">
          Surfers' myelopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         A syndrome of acute low back pain followed by progressive lower extremity numbness and weakness has been described in at least 26 patients while surfing [
         <a href="#rid188">
          188-193
         </a>
         ]. Patients are generally young (ages 15 to 46 years), mostly male, are often surfing for the first time, and have suffered no apparent trauma. MRI shows restricted diffusion in the lower thoracic spinal cord to the conus medullaris. The pathogenesis is unclear; however, the MRI findings along with reports of individuals lying prone on the surfboard with possible lumbar hyperextension for prolonged periods of time suggest that vascular compression may play a role. The severity of the neurologic deficits and degree of recovery is variable.
        </p>
        <p class="headingAnchor" id="H182766185">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/17207.html" rel="external">
          "Patient education: Paraplegia and quadriplegia (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/83432.html" rel="external">
          "Patient education: Friedreich ataxia (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H35">
         <span class="h1">
          SUMMARY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pathologies that affect the spinal cord are diverse. Common etiologies of myelopathy include autoimmune, infectious, neoplastic, vascular, and hereditary-degenerative diseases. The neurologic examination will characterize the deficits as to the spinal cord syndrome. (See
         <a class="medical medical_review" href="/z/d/html/5110.html" rel="external">
          "Anatomy and localization of spinal cord disorders"
         </a>
         .)
        </p>
        <p>
         The spinal cord syndrome along with the clinical setting and course of presentation with the findings on a neuroimaging study (usually magnetic resonance imaging [MRI]) will identify the likely pathogenesis in most cases  (
         <a class="graphic graphic_table graphicRef50336" href="/z/d/graphic/50336.html" rel="external">
          table 1
         </a>
         ). (See individual topic reviews above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Moore AP, Blumhardt LD. A prospective survey of the causes of non-traumatic spastic paraparesis and tetraparesis in 585 patients. Spinal Cord 1997; 35:361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brinar VV, Habek M, Brinar M, et al. The differential diagnosis of acute transverse myelitis. Clin Neurol Neurosurg 2006; 108:278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Budka H. Neuropathology of myelitis, myelopathy, and spinal infections in AIDS. Neuroimaging Clin N Am 1997; 7:639.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cree BA, Wingerchuk DM. Acute transverse myelitis: is the "idiopathic" form vanishing? Neurology 2005; 65:1857.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jeffery DR, Mandler RN, Davis LE. Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 1993; 50:532.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Seze J, Lanctin C, Lebrun C, et al. Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology 2005; 65:1950.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaplin AI, Krishnan C, Deshpande DM, et al. Diagnosis and management of acute myelopathies. Neurologist 2005; 11:2.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pidcock FS, Krishnan C, Crawford TO, et al. Acute transverse myelitis in childhood: center-based analysis of 47 cases. Neurology 2007; 68:1474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thorpe JW, Kidd D, Moseley IF, et al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 1996; 119 ( Pt 3):709.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lehnhardt FG, Impekoven P, Rubbert A, et al. Recurrent longitudinal myelitis as primary manifestation of SLE. Neurology 2004; 63:1976.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krishnan AV, Halmagyi GM. Acute transverse myelitis in SLE. Neurology 2004; 62:2087.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mok CC, Lau CS. Transverse myelopathy complicating mixed connective tissue disease. Clin Neurol Neurosurg 1995; 97:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anantharaju A, Baluch M, Van Thiel DH. Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren's syndrome. Dig Dis Sci 2003; 48:830.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rabadi MH, Kundi S, Brett D, Padmanabhan R. Neurological pictures. Primary Sjögren syndrome presenting as neuromyelitis optica. J Neurol Neurosurg Psychiatry 2010; 81:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Torabi AM, Patel RK, Wolfe GI, et al. Transverse myelitis in systemic sclerosis. Arch Neurol 2004; 61:126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oh DH, Jun JB, Kim HT, et al. Transverse myelitis in a patient with long-standing ankylosing spondylitis. Clin Exp Rheumatol 2001; 19:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harzheim M, Schlegel U, Urbach H, et al. Discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients. J Neurol Sci 2004; 217:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knebusch M, Strassburg HM, Reiners K. Acute transverse myelitis in childhood: nine cases and review of the literature. Dev Med Child Neurol 1998; 40:631.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bakshi R, Kinkel PR, Mechtler LL, et al. Magnetic resonance imaging findings in 22 cases of myelitis: comparison between patients with and without multiple sclerosis. Eur J Neurol 1998; 5:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi KH, Lee KS, Chung SO, et al. Idiopathic transverse myelitis: MR characteristics. AJNR Am J Neuroradiol 1996; 17:1151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cordonnier C, de Seze J, Breteau G, et al. Prospective study of patients presenting with acute partial transverse myelopathy. J Neurol 2003; 250:1447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Defresne P, Hollenberg H, Husson B, et al. Acute transverse myelitis in children: clinical course and prognostic factors. J Child Neurol 2003; 18:401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bruna J, Martínez-Yélamos S, Martínez-Yélamos A, et al. Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler 2006; 12:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seifert T, Enzinger C, Ropele S, et al. Relapsing acute transverse myelitis: a specific entity. Eur J Neurol 2005; 12:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim KK. Idiopathic recurrent transverse myelitis. Arch Neurol 2003; 60:1290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenberg BM, Thomas KP, Krishnan C, et al. Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide. Neurology 2007; 68:1614.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scott TF, Bhagavatula K, Snyder PJ, Chieffe C. Transverse myelitis. Comparison with spinal cord presentations of multiple sclerosis. Neurology 1998; 50:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ford B, Tampieri D, Francis G. Long-term follow-up of acute partial transverse myelopathy. Neurology 1992; 42:250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar N, Frohman EM. Spinal neurosarcoidosis mimicking an idiopathic inflammatory demyelinating syndrome. Arch Neurol 2004; 61:586.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Junger SS, Stern BJ, Levine SR, et al. Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics. Neurology 1993; 43:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saleh S, Saw C, Marzouk K, Sharma O. Sarcoidosis of the spinal cord: literature review and report of eight cases. J Natl Med Assoc 2006; 98:965.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenfeld MR, Posner JB. Paraneoplastic motor neuron disease. Adv Neurol 1991; 56:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ojeda VJ. Necrotizing myelopathy associated with malignancy. A clinicopathologic study of two cases and literature review. Cancer 1984; 53:1115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 1992; 71:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Darouiche RO. Spinal epidural abscess. N Engl J Med 2006; 355:2012.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woolsey RM, McGarry JD. AIDS related spinal cord syndromes. J Am Paraplegia Soc 1989; 12:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Solomon T, Willison H. Infectious causes of acute flaccid paralysis. Curr Opin Infect Dis 2003; 16:375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen CY, Chang YC, Huang CC, et al. Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. AJNR Am J Neuroradiol 2001; 22:200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           John TJ. Spinal cord disease in West Nile virus infection. N Engl J Med 2003; 348:564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelley TW, Prayson RA, Isada CM. Spinal cord disease in West Nile virus infection. N Engl J Med 2003; 348:564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jeha LE, Sila CA, Lederman RJ, et al. West Nile virus infection: a new acute paralytic illness. Neurology 2003; 61:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kraushaar G, Patel R, Stoneham GW. West Nile Virus: a case report with flaccid paralysis and cervical spinal cord: MR imaging findings. AJNR Am J Neuroradiol 2005; 26:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cao NJ, Ranganathan C, Kupsky WJ, Li J. Recovery and prognosticators of paralysis in West Nile virus infection. J Neurol Sci 2005; 236:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arya SC, Agarwal N. Spinal cord neuropathology in human West Nile virus infection. Arch Pathol Lab Med 2004; 128:1210; author reply 1210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fux CA, Pfister S, Nohl F, Zimmerli S. Cytomegalovirus-associated acute transverse myelitis in immunocompetent adults. Clin Microbiol Infect 2003; 9:1187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nakajima H, Furutama D, Kimura F, et al. Herpes simplex virus myelitis: clinical manifestations and diagnosis by the polymerase chain reaction method. Eur Neurol 1998; 39:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shyu WC, Lin JC, Chang BC, et al. Recurrent ascending myelitis: an unusual presentation of herpes simplex virus type 1 infection. Ann Neurol 1993; 34:625.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kincaid O, Lipton HL. Viral myelitis: an update. Curr Neurol Neurosci Rep 2006; 6:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aktipi KM, Ravaglia S, Ceroni M, et al. Severe recurrent myelitis in patients with hepatitis C virus infection. Neurology 2007; 68:468.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orme HT, Smith AG, Nagel MA, et al. VZV spinal cord infarction identified by diffusion-weighted MRI (DWI). Neurology 2007; 69:398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Young-Barbee C, Hall DA, LoPresti JJ, et al. Brown-Séquard syndrome after herpes zoster. Neurology 2009; 72:670.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Di Rocco A. Diseases of the spinal cord in human immunodeficiency virus infection. Semin Neurol 1999; 19:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dal Pan GJ, Glass JD, McArthur JC. Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study. Neurology 1994; 44:2159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Staudinger R, Henry K. Remission of HIV myelopathy after highly active antiretroviral therapy. Neurology 2000; 54:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cikurel K, Schiff L, Simpson DM. Pilot study of intravenous immunoglobulin in HIV-associated myelopathy. AIDS Patient Care STDS 2009; 23:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geraci A, Di Rocco A, Liu M, et al. AIDS myelopathy is not associated with elevated HIV viral load in cerebrospinal fluid. Neurology 2000; 55:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grindstaff P, Gruener G. The peripheral nervous system complications of HTLV-1 myelopathy (HAM/TSP) syndromes. Semin Neurol 2005; 25:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 353:1951.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oger J, Dekaban G. HTLV-I associated myelopathy: a case of viral-induced auto-immunity. Autoimmunity 1995; 21:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oger JJ, Werker DH, Foti DJ, Dekaban GA. HTLV-I associated myelopathy: an endemic disease of Canadian aboriginals of the Northwest Pacific coast? Can J Neurol Sci 1993; 20:302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leite AC, Mendonça GA, Serpa MJ, et al. Neurological manifestations in HTLV-I-infected blood donors. J Neurol Sci 2003; 214:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nagai M, Osame M. Human T-cell lymphotropic virus type I and neurological diseases. J Neurovirol 2003; 9:228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu W, Nair G, Vuolo L, et al. In vivo imaging of spinal cord atrophy in neuroinflammatory diseases. Ann Neurol 2014; 76:370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chilver-Stainer L, Fischer U, Hauf M, et al. Syphilitic myelitis: rare, nonspecific, but treatable. Neurology 2009; 72:673.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balériaux DL, Neugroschl C. Spinal and spinal cord infection. Eur Radiol 2004; 14 Suppl 3:E72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           al-Deeb SM, Yaqub BA, Sharif HS, Motaery KR. Neurotuberculosis: a review. Clin Neurol Neurosurg 1992; 94 Suppl:S30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bahemuka M, Murungi JH. Tuberculosis of the nervous system. A clinical, radiological and pathological study of 39 consecutive cases in Riyadh, Saudi Arabia. J Neurol Sci 1989; 90:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scrimgeour EM, Gajdusek DC. Involvement of the central nervous system in Schistosoma mansoni and S. haematobium infection. A review. Brain 1985; 108 ( Pt 4):1023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferrari TC. Spinal cord schistosomiasis. A report of 2 cases and review emphasizing clinical aspects. Medicine (Baltimore) 1999; 78:176.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gonçalves FG, Neves PO, Jovem CL, et al. Chronic myelopathy associated to intramedullary cysticercosis. Spine (Phila Pa 1976) 2010; 35:E159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kastenbauer S, Winkler F, Fesl G, et al. Acute severe spinal cord dysfunction in bacterial meningitis in adults: MRI findings suggest extensive myelitis. Arch Neurol 2001; 58:806.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Josephson SA, Pillai DR, Phillips JJ, Chou D. Neurolisteriosis presenting as cervical myelitis in an immunocompetent patient. Neurology 2006; 66:1122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mantienne C, Albucher JF, Catalaa I, et al. MRI in Lyme disease of the spinal cord. Neuroradiology 2001; 43:485.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meurs L, Labeye D, Declercq I, et al. Acute transverse myelitis as a main manifestation of early stage II neuroborreliosis in two patients. Eur Neurol 2004; 52:186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheshire WP, Santos CC, Massey EW, Howard JF Jr. Spinal cord infarction: etiology and outcome. Neurology 1996; 47:321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Faig J, Busse O, Salbeck R. Vertebral body infarction as a confirmatory sign of spinal cord ischemic stroke: report of three cases and review of the literature. Stroke 1998; 29:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fairhead JF, Phillips D, Handa A. Embolic spinal cord infarction as a presentation of abdominal aortic aneurysm. J R Soc Med 2005; 98:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salvarani C, Brown RD Jr, Calamia KT, et al. Primary CNS vasculitis with spinal cord involvement. Neurology 2008; 70:2394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Masson C, Pruvo JP, Meder JF, et al. Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome. J Neurol Neurosurg Psychiatry 2004; 75:1431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weidauer S, Nichtweiss M, Lanfermann H, Zanella FE. Spinal cord infarction: MR imaging and clinical features in 16 cases. Neuroradiology 2002; 44:851.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Küker W, Weller M, Klose U, et al. Diffusion-weighted MRI of spinal cord infarction--high resolution imaging and time course of diffusion abnormality. J Neurol 2004; 251:818.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shinoyama M, Takahashi T, Shimizu H, et al. Spinal cord infarction demonstrated by diffusion-weighted magnetic resonance imaging. J Clin Neurosci 2005; 12:466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thurnher MM, Bammer R. Diffusion-weighted MR imaging (DWI) in spinal cord ischemia. Neuroradiology 2006; 48:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pelser H, van Gijn J. Spinal infarction. A follow-up study. Stroke 1993; 24:896.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Riche MC, Reizine D, Melki JP, Merland JJ. Classification of spinal cord vascular malformations. Radiat Med 1985; 3:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bemporad JA, Sze GS. MR imaging of spinal cord vascular malformations with an emphasis on the cervical spine. Magn Reson Imaging Clin N Am 2000; 8:581.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lev N, Maimon S, Rappaport ZH, Melamed E. Spinal dural arteriovenous fistulae--a diagnostic challenge. Isr Med Assoc J 2001; 3:492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muralidharan R, Saladino A, Lanzino G, et al. The clinical and radiological presentation of spinal dural arteriovenous fistula. Spine (Phila Pa 1976) 2011; 36:E1641.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luetmer PH, Lane JI, Gilbertson JR, et al. Preangiographic evaluation of spinal dural arteriovenous fistulas with elliptic centric contrast-enhanced MR Angiography and effect on radiation dose and volume of iodinated contrast material. AJNR Am J Neuroradiol 2005; 26:711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saraf-Lavi E, Bowen BC, Quencer RM, et al. Detection of spinal dural arteriovenous fistulae with MR imaging and contrast-enhanced MR angiography: sensitivity, specificity, and prediction of vertebral level. AJNR Am J Neuroradiol 2002; 23:858.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bemporad JA, Sze G. Magnetic resonance imaging of spinal cord vascular malformations with an emphasis on the cervical spine. Neuroimaging Clin N Am 2001; 11:viii, 111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koch C. Spinal dural arteriovenous fistula. Curr Opin Neurol 2006; 19:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toossi S, Josephson SA, Hetts SW, et al. Utility of MRI in spinal arteriovenous fistula. Neurology 2012; 79:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen J, Gailloud P. Safety of spinal angiography: complication rate analysis in 302 diagnostic angiograms. Neurology 2011; 77:1235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watson JC, Oldfield EH. The surgical management of spinal dural vascular malformations. Neurosurg Clin N Am 1999; 10:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aghakhani N, Parker F, David P, et al. Curable cause of paraplegia: spinal dural arteriovenous fistulae. Stroke 2008; 39:2756.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kilic AK, Kurne AT, Saatci I, Tan E. A rare cause of radiculomyelitis: dural arteriovenous fistula. JAMA Neurol 2015; 72:217.
          </a>
         </li>
         <li class="breakAll">
          Yasargil MG, Symon L, Teddy PG. Arteriovenous malformations of the spinal cord. In: Advances and Technical Standards in Neurosurgery, Symon L (Ed), Springer, Wien 1984. p.61.
         </li>
         <li class="breakAll">
          Aminoff MJ. Spinal vascular disease. In: Spinal Cord Disease: Basic Science, Diagnosis and Management, Critchley E, Eisen A (Eds), Springer, London 1992. p.423.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zozulya YP, Slin'ko EI, Al-Qashqish II. Spinal arteriovenous malformations: new classification and surgical treatment. Neurosurg Focus 2006; 20:E7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Furlan JC, Hawryluk GW, Austin J, Fehlings MG. Spinal haemorrhage during anticoagulant regimen for thromboprophylaxis: a unique form of central nervous system haemorrhage. J Neurol Neurosurg Psychiatry 2012; 83:746.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thiele RH, Hage ZA, Surdell DL, et al. Spontaneous spinal epidural hematoma of unknown etiology: case report and literature review. Neurocrit Care 2008; 9:242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu WH, Hsieh CT, Chiang YH, Chen GJ. Spontaneous spinal epidural hematoma of thoracic spine: a rare case report and review of literature. Am J Emerg Med 2008; 26:384.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           SreeHarsha CK, Rajasekaran S, Dhanasekararaja P. Spontaneous complete recovery of paraplegia caused by epidural hematoma complicating epidural anesthesia: a case report and review of literature. Spinal Cord 2006; 44:514.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Braun P, Kazmi K, Nogués-Meléndez P, et al. MRI findings in spinal subdural and epidural hematomas. Eur J Radiol 2007; 64:119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg 1994; 79:1165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lawton MT, Porter RW, Heiserman JE, et al. Surgical management of spinal epidural hematoma: relationship between surgical timing and neurological outcome. J Neurosurg 1995; 83:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hemmer B, Glocker FX, Schumacher M, et al. Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings. J Neurol Neurosurg Psychiatry 1998; 65:822.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318:1720.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vasconcelos OM, Poehm EH, McCarter RJ, et al. Potential outcome factors in subacute combined degeneration: review of observational studies. J Gen Intern Med 2006; 21:1063.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diamond AL, Diamond R, Freedman SM, Thomas FP. "Whippets"-induced cobalamin deficiency manifesting as cervical myelopathy. J Neuroimaging 2004; 14:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doran M, Rassam SS, Jones LM, Underhill S. Toxicity after intermittent inhalation of nitrous oxide for analgesia. BMJ 2004; 328:1364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ng J, Frith R. Nanging. Lancet 2002; 360:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sotirchos ES, Saidha S, Becker D. Neurological picture. Nitrous oxide-induced myelopathy with inverted V-sign on spinal MRI. J Neurol Neurosurg Psychiatry 2012; 83:915.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar N, Gross JB Jr, Ahlskog JE. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology 2004; 63:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nations SP, Boyer PJ, Love LA, et al. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology 2008; 71:639.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goodman BP, Bosch EP, Ross MA, et al. Clinical and electrodiagnostic findings in copper deficiency myeloneuropathy. J Neurol Neurosurg Psychiatry 2009; 80:524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldwein JW. Radiation myelopathy: a review. Med Pediatr Oncol 1987; 15:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schultheiss TE, Stephens LC. Invited review: permanent radiation myelopathy. Br J Radiol 1992; 65:737.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Okada S, Okeda R. Pathology of radiation myelopathy. Neuropathology 2001; 21:247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schultheiss TE, Stephens LC. The pathogenesis of radiation myelopathy: widening the circle. Int J Radiat Oncol Biol Phys 1992; 23:1089.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ang KK, Stephens LC. Prevention and management of radiation myelopathy. Oncology (Williston Park) 1994; 8:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwendimann RN. Metabolic, nutritional, and toxic myelopathies. Neurol Clin 2013; 31:207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cachia D, Kamiya-Matsuoka C, Pinnix CC, et al. Myelopathy following intrathecal chemotherapy in adults: a single institution experience. J Neurooncol 2015; 122:391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chamberlain MC. Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series. J Neurooncol 2012; 109:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chamberlain MC. Neurotoxicity of cancer treatment. Curr Oncol Rep 2010; 12:60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goodman BP. Metabolic and toxic causes of myelopathy. Continuum (Minneap Minn) 2015; 21:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ten Duis HJ, Klasen HJ, Reenalda PE. Keraunoparalysis, a 'specific' lightning injury. Burns Incl Therm Inj 1985; 12:54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cherington M. Neurologic manifestations of lightning strikes. Neurology 2003; 60:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Breugem CC, Van Hertum W, Groenevelt F. High voltage electrical injury leading to a delayed onset tetraplegia, with recovery. Ann N Y Acad Sci 1999; 888:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kalita J, Jose M, Misra UK. Myelopathy and amnesia following accidental electrical injury. Spinal Cord 2002; 40:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ko SH, Chun W, Kim HC. Delayed spinal cord injury following electrical burns: a 7-year experience. Burns 2004; 30:691.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lammertse DP. Neurorehabilitation of spinal cord injuries following lightning and electrical trauma. NeuroRehabilitation 2005; 20:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Utku U, Asil T, Balci K, et al. Hepatic myelopathy with spastic paraparesis. Clin Neurol Neurosurg 2005; 107:514.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Campellone JV, Lacomis D, Giuliani MJ, Kroboth FJ. Hepatic myelopathy. Case report with review of the literature. Clin Neurol Neurosurg 1996; 98:242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobukawa E, Sakimura K, Hoshino S, et al. Hepatic myelopathy: an unusual neurological complication of advanced hepatic disease. Intern Med 1994; 33:718.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conn HO, Rössle M, Levy L, Glocker FX. Portosystemic myelopathy: spastic paraparesis after portosystemic shunting. Scand J Gastroenterol 2006; 41:619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nardone R, Buratti T, Oliviero A, et al. Corticospinal involvement in patients with a portosystemic shunt due to liver cirrhosis: a MEP study. J Neurol 2006; 253:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barratt DM, Van Meter K. Decompression sickness in Miskito Indian lobster divers: review of 229 cases. Aviat Space Environ Med 2004; 75:350.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aharon-Peretz J, Adir Y, Gordon CR, et al. Spinal cord decompression sickness in sport diving. Arch Neurol 1993; 50:753.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mastaglia FL, McCallum RI, Walder DN. Myelopathy associated with decompression sickness: a report of six cases. Clin Exp Neurol 1983; 19:54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCormac J, Mirvis SE, Cotta-Cumba C, Shanmuganathan K. Spinal myelopathy resulting from decompression sickness: MR findings in a case and review of the literature. Emerg Radiol 2002; 9:240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tournebise H, Boucand MH, Landi J, Theobald X. Paraplegia and decompression sickness. Paraplegia 1995; 33:636.
          </a>
         </li>
         <li class="breakAll">
          Tshala-Katumbay D, Spencer PS. Toxic disorders of the upper motor neuron system. In: Motor Neuron Diseases, Eisen A, Shaw PM (Eds), Elsevier, Edinburgh 2006. p.353.
         </li>
         <li class="breakAll">
          Eeg-Olofsson KE, Tshala-Katumbay D. Konzo. In: Clinical Neurophysiology of Motor Neuron Diseases, Elsevier, Amsterdam 2005. p.675.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ludolph AC, Hugon J, Dwivedi MP, et al. Studies on the aetiology and pathogenesis of motor neuron diseases. 1. Lathyrism: clinical findings in established cases. Brain 1987; 110 ( Pt 1):149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tshala-Katumbay D, Edebol Eeg-Olofsson K, Kazadi-Kayembe T, et al. Abnormalities of somatosensory evoked potentials in konzo--an upper motor neuron disorder. Clin Neurophysiol 2002; 113:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tshala-Katumbay D, Eeg-Olofsson KE, Kazadi-Kayembe T, et al. Analysis of motor pathway involvement in konzo using transcranial electrical and magnetic stimulation. Muscle Nerve 2002; 25:230.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Helweg-Larsen S, Sørensen PS. Symptoms and signs in metastatic spinal cord compression: a study of progression from first symptom until diagnosis in 153 patients. Eur J Cancer 1994; 30A:396.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Helweg-Larsen S, Sørensen PS, Kreiner S. Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys 2000; 46:1163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shrivastava RK, Epstein FJ, Perin NI, et al. Intramedullary spinal cord tumors in patients older than 50 years of age: management and outcome analysis. J Neurosurg Spine 2005; 2:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graber JJ, Nolan CP. Myelopathies in patients with cancer. Arch Neurol 2010; 67:298.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sevick RJ, Wallace CJ. MR imaging of neoplasms of the lumbar spine. Magn Reson Imaging Clin N Am 1999; 7:539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rowland LP. Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1998; 160 Suppl 1:S6.
          </a>
         </li>
         <li class="breakAll">
          Mitsumoto H, Chad DA, Pioro EP. Amyotrophic lateral sclerosis. In: Contemporary Neurology Series, 49, FA Davis Company, 1998.
         </li>
         <li class="breakAll">
          Eisen A. Primary lateral slcerosis. In: Handbook of Clinical Neurology, Vol 82, Eisen A, Shaw PM (Eds), Elsevier, Edinburgh 2007. p.315.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhai P, Pagan F, Statland J, et al. Primary lateral sclerosis: A heterogeneous disorder composed of different subtypes? Neurology 2003; 60:1258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andersen PM, Nilsson P, Keränen ML, et al. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 1997; 120 ( Pt 10):1723.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andersen PM, Forsgren L, Binzer M, et al. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain 1996; 119 ( Pt 4):1153.
          </a>
         </li>
         <li class="breakAll">
          Eisen A, Krieger C. Amyotrophic Lateral Sclerosis. A Synthesis of Research and Clinical Practice, Cambridge University Press, 1998.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber M, Eisen A, Stewart HG, Andersen PM. Preserved slow conducting corticomotoneuronal projections in amyotrophic lateral sclerosis with autosomal recessive D90A CuZn-superoxide dismutase mutation. Brain 2000; 123 ( Pt 7):1505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salinas S, Proukakis C, Crosby A, Warner TT. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol 2008; 7:1127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fink JK. Hereditary spastic paraplegia. Neurol Clin 2002; 20:711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fink JK. Hereditary spastic paraplegia. Curr Neurol Neurosci Rep 2006; 6:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gould RM, Brady ST. Neuropathology: many paths lead to hereditary spastic paraplegia. Curr Biol 2004; 14:R903.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McDermott CJ, Shaw PJ. Hereditary spastic paraplegia. Int Rev Neurobiol 2002; 53:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reid E. Many pathways lead to hereditary spastic paraplegia. Lancet Neurol 2003; 2:210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boukhris A, Stevanin G, Feki I, et al. Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15, and further genetic heterogeneity. Arch Neurol 2008; 65:393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moser HW, Mahmood A, Raymond GV. X-linked adrenoleukodystrophy. Nat Clin Pract Neurol 2007; 3:140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Griffin JW, Goren E, Schaumburg H, et al. Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects. Neurology 1977; 27:1107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dürr A, Cossee M, Agid Y, et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 1996; 335:1169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhidayasiri R, Perlman SL, Pulst SM, Geschwind DH. Late-onset Friedreich ataxia: phenotypic analysis, magnetic resonance imaging findings, and review of the literature. Arch Neurol 2005; 62:1865.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milhorat TH. Classification of syringomyelia. Neurosurg Focus 2000; 8:E1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brickell KL, Anderson NE, Charleston AJ, et al. Ethnic differences in syringomyelia in New Zealand. J Neurol Neurosurg Psychiatry 2006; 77:989.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Larner AJ, Muqit MM, Glickman S. Concurrent syrinx and inflammatory central nervous system disease detected by magnetic resonance imaging: an illustrative case and review of the literature. Medicine (Baltimore) 2002; 81:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laxton AW, Perrin RG. Cordectomy for the treatment of posttraumatic syringomyelia. Report of four cases and review of the literature. J Neurosurg Spine 2006; 4:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Batzdorf U. Primary spinal syringomyelia: a personal perspective. Neurosurg Focus 2000; 8:E7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Todor DR, Mu HT, Milhorat TH. Pain and syringomyelia: a review. Neurosurg Focus 2000; 8:E11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCormick WE, Steinmetz MP, Benzel EC. Cervical spondylotic myelopathy: make the difficult diagnosis, then refer for surgery. Cleve Clin J Med 2003; 70:899.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baron EM, Young WF. Cervical spondylotic myelopathy: a brief review of its pathophysiology, clinical course, and diagnosis. Neurosurgery 2007; 60:S35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi BW, Song KJ, Chang H. Ossification of the posterior longitudinal ligament: a review of literature. Asian Spine J 2011; 5:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mochizuki M, Aiba A, Hashimoto M, et al. Cervical myelopathy in patients with ossification of the posterior longitudinal ligament. J Neurosurg Spine 2009; 10:122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matsunaga S, Sakou T. Ossification of the posterior longitudinal ligament of the cervical spine: etiology and natural history. Spine (Phila Pa 1976) 2012; 37:E309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saetia K, Cho D, Lee S, et al. Ossification of the posterior longitudinal ligament: a review. Neurosurg Focus 2011; 30:E1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jeon TS, Chang H, Choi BW. Analysis of demographics, clinical, and radiographical findings of ossification of posterior longitudinal ligament of the cervical spine in 146 Korean patients. Spine (Phila Pa 1976) 2012; 37:E1498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fujimori T, Le H, Hu SS, et al. Ossification of the posterior longitudinal ligament of the cervical spine in 3161 patients: a CT-based study. Spine (Phila Pa 1976) 2015; 40:E394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Onishi E, Sakamoto A, Murata S, Matsushita M. Risk factors for acute cervical spinal cord injury associated with ossification of the posterior longitudinal ligament. Spine (Phila Pa 1976) 2012; 37:660.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang CW, Donovan DJ, Liem LK, et al. Surfers' myelopathy: a case series of 19 novice surfers with nontraumatic myelopathy. Neurology 2012; 79:2171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lieske J, Cameron B, Drinkwine B, et al. Surfer's myelopathy-demonstrated by diffusion-weighted magnetic resonance imaging: a case report and literature review. J Comput Assist Tomogr 2011; 35:492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takakura T, Yokoyama O, Sakuma F, et al. Complete paraplegia resulting from surfer's myelopathy. Am J Phys Med Rehabil 2013; 92:833.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fessa CK, Lee BS. An Australian case of surfer's myelopathy. Clin J Sport Med 2012; 22:281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chung HY, Sun SF, Wang JL, et al. Non-traumatic anterior spinal cord infarction in a novice surfer: a case report. J Neurol Sci 2011; 302:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shuster A, Franchetto A. Surfer's myelopathy--an unusual cause of acute spinal cord ischemia: a case report and review of the literature. Emerg Radiol 2011; 18:57.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5093 Version 18.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9194258" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : A prospective survey of the causes of non-traumatic spastic paraparesis and tetraparesis in 585 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16376014" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : The differential diagnosis of acute transverse myelitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9376972" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Neuropathology of myelitis, myelopathy, and spinal infections in AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16380606" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Acute transverse myelitis: is the "idiopathic" form vanishing?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8489410" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16380618" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Idiopathic acute transverse myelitis: application of the recent diagnostic criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15631640" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Diagnosis and management of acute myelopathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17470749" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Acute transverse myelitis in childhood: center-based analysis of 47 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8673484" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15557531" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Recurrent longitudinal myelitis as primary manifestation of SLE.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15184619" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Acute transverse myelitis in SLE.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7586861" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Transverse myelopathy complicating mixed connective tissue disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12741480" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20145030" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Neurological pictures. Primary Sjögren syndrome presenting as neuromyelitis optica.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14732630" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Transverse myelitis in systemic sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11326484" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Transverse myelitis in a patient with long-standing ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14706227" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9766742" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Acute transverse myelitis in childhood: nine cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10210810" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Magnetic resonance imaging findings in 22 cases of myelitis: comparison between patients with and without multiple sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8791931" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Idiopathic transverse myelitis: MR characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14673577" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Prospective study of patients presenting with acute partial transverse myelopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12886975" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Acute transverse myelitis in children: clinical course and prognostic factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16629419" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16128868" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Relapsing acute transverse myelitis: a specific entity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12975297" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Idiopathic recurrent transverse myelitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17485649" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9484367" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Transverse myelitis. Comparison with spinal cord presentations of multiple sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1285728" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Long-term follow-up of acute partial transverse myelopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15096410" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Spinal neurosarcoidosis mimicking an idiopathic inflammatory demyelinating syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8437698" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16775923" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Sarcoidosis of the spinal cord: literature review and report of eight cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1853777" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Paraneoplastic motor neuron disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6362838" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Necrotizing myelopathy associated with malignancy. A clinicopathologic study of two cases and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1312211" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17093252" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Spinal epidural abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2532241" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : AIDS related spinal cord syndromes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14501988" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Infectious causes of acute flaccid paralysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11158910" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12575663" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Spinal cord disease in West Nile virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12571269" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Spinal cord disease in West Nile virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12847156" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : West Nile virus infection: a new acute paralytic illness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15661693" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : West Nile Virus: a case report with flaccid paralysis and cervical spinal cord: MR imaging findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15967468" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Recovery and prognosticators of paralysis in West Nile virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15504051" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Spinal cord neuropathology in human West Nile virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14686983" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Cytomegalovirus-associated acute transverse myelitis in immunocompetent adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9605393" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Herpes simplex virus myelitis: clinical manifestations and diagnosis by the polymerase chain reaction method.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8215253" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Recurrent ascending myelitis: an unusual presentation of herpes simplex virus type 1 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17074281" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Viral myelitis: an update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17283325" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Severe recurrent myelitis in patients with hepatitis C virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17646633" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : VZV spinal cord infarction identified by diffusion-weighted MRI (DWI).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19221302" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Brown-Séquard syndrome after herpes zoster.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10718535" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Diseases of the spinal cord in human immunodeficiency virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7969977" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10636172" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Remission of HIV myelopathy after highly active antiretroviral therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19196033" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Pilot study of intravenous immunoglobulin in HIV-associated myelopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10932285" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : AIDS myelopathy is not associated with elevated HIV viral load in cerebrospinal fluid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16170744" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : The peripheral nervous system complications of HTLV-1 myelopathy (HAM/TSP) syndromes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10371587" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Human T-lymphotropic virus type I infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8822273" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : HTLV-I associated myelopathy: a case of viral-induced auto-immunity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8313245" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : HTLV-I associated myelopathy: an endemic disease of Canadian aboriginals of the Northwest Pacific coast?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12972388" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Neurological manifestations in HTLV-I-infected blood donors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12707853" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Human T-cell lymphotropic virus type I and neurological diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25042583" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : In vivo imaging of spinal cord atrophy in neuroinflammatory diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19221304" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Syphilitic myelitis: rare, nonspecific, but treatable.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14749951" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Spinal and spinal cord infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1320510" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Neurotuberculosis: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2723675" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Tuberculosis of the nervous system. A clinical, radiological and pathological study of 39 consecutive cases in Riyadh, Saudi Arabia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3935269" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Involvement of the central nervous system in Schistosoma mansoni and S. haematobium infection. A review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10352649" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Spinal cord schistosomiasis. A report of 2 cases and review emphasizing clinical aspects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20147871" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Chronic myelopathy associated to intramedullary cysticercosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11346376" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Acute severe spinal cord dysfunction in bacterial meningitis in adults: MRI findings suggest extensive myelitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16606936" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Neurolisteriosis presenting as cervical myelitis in an immunocompetent patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11465762" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : MRI in Lyme disease of the spinal cord.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15528925" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Acute transverse myelitis as a main manifestation of early stage II neuroborreliosis in two patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8757000" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Spinal cord infarction: etiology and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9445357" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Vertebral body infarction as a confirmatory sign of spinal cord ischemic stroke: report of three cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15684355" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Embolic spinal cord infarction as a presentation of abdominal aortic aneurysm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18541872" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Primary CNS vasculitis with spinal cord involvement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15377691" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12389137" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Spinal cord infarction: MR imaging and clinical features in 16 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15258783" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Diffusion-weighted MRI of spinal cord infarction--high resolution imaging and time course of diffusion abnormality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15925784" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Spinal cord infarction demonstrated by diffusion-weighted magnetic resonance imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16977443" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Diffusion-weighted MR imaging (DWI) in spinal cord ischemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8506562" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Spinal infarction. A follow-up study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4070669" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Classification of spinal cord vascular malformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10947928" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : MR imaging of spinal cord vascular malformations with an emphasis on the cervical spine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11791414" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Spinal dural arteriovenous fistulae--a diagnostic challenge.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21336239" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : The clinical and radiological presentation of spinal dural arteriovenous fistula.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15814910" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Preangiographic evaluation of spinal dural arteriovenous fistulas with elliptic centric contrast-enhanced MR Angiography and effect on radiation dose and volume of iodinated contrast material.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12006294" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Detection of spinal dural arteriovenous fistulae with MR imaging and contrast-enhanced MR angiography: sensitivity, specificity, and prediction of vertebral level.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11331230" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Magnetic resonance imaging of spinal cord vascular malformations with an emphasis on the cervical spine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16415680" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Spinal dural arteriovenous fistula.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22592367" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Utility of MRI in spinal arteriovenous fistula.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21917768" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Safety of spinal angiography: complication rate analysis in 302 diagnostic angiograms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9855650" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : The surgical management of spinal dural vascular malformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18635837" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Curable cause of paraplegia: spinal dural arteriovenous fistulae.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25436872" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : A rare cause of radiculomyelitis: dural arteriovenous fistula.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25436872" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : A rare cause of radiculomyelitis: dural arteriovenous fistula.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25436872" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : A rare cause of radiculomyelitis: dural arteriovenous fistula.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16711664" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Spinal arteriovenous malformations: new classification and surgical treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22566595" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Spinal haemorrhage during anticoagulant regimen for thromboprophylaxis: a unique form of central nervous system haemorrhage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18373224" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Spontaneous spinal epidural hematoma of unknown etiology: case report and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18358974" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Spontaneous spinal epidural hematoma of thoracic spine: a rare case report and review of literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16317425" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Spontaneous complete recovery of paraplegia caused by epidural hematoma complicating epidural anesthesia: a case report and review of literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17353109" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : MRI findings in spinal subdural and epidural hematomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7978443" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Anticoagulants and spinal-epidural anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7782824" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Surgical management of spinal epidural hematoma: relationship between surgical timing and neurological outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9854956" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3374544" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16970556" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Potential outcome factors in subacute combined degeneration: review of observational studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15228771" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : "Whippets"-induced cobalamin deficiency manifesting as cervical myelopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15178617" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Toxicity after intermittent inhalation of nitrous oxide for analgesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12241780" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Nanging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22773860" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Neurological picture. Nitrous oxide-induced myelopathy with inverted V-sign on spinal MRI.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15249607" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18525032" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18495738" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Clinical and electrodiagnostic findings in copper deficiency myeloneuropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3295502" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Radiation myelopathy: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1393407" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Invited review: permanent radiation myelopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11837531" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Pathology of radiation myelopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1639645" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : The pathogenesis of radiation myelopathy: widening the circle.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7826840" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Prevention and management of radiation myelopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23186901" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Metabolic, nutritional, and toxic myelopathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25666482" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Myelopathy following intrathecal chemotherapy in adults: a single institution experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22539243" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20425609" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Neurotoxicity of cancer treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25651219" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Metabolic and toxic causes of myelopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4063869" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Keraunoparalysis, a 'specific' lightning injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12557851" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Neurologic manifestations of lightning strikes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10842627" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : High voltage electrical injury leading to a delayed onset tetraplegia, with recovery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11987009" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Myelopathy and amnesia following accidental electrical injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15475144" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Delayed spinal cord injury following electrical burns: a 7-year experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15798350" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Neurorehabilitation of spinal cord injuries following lightning and electrical trauma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16202825" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Hepatic myelopathy with spastic paraparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8884097" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Hepatic myelopathy. Case report with review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7849390" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Hepatic myelopathy: an unusual neurological complication of advanced hepatic disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16638707" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Portosystemic myelopathy: spastic paraparesis after portosystemic shunting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16047111" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : Corticospinal involvement in patients with a portosystemic shunt due to liver cirrhosis: a MEP study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15086125" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Decompression sickness in Miskito Indian lobster divers: review of 229 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8323480" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : Spinal cord decompression sickness in sport diving.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6568929" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Myelopathy associated with decompression sickness: a report of six cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15290571" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Spinal myelopathy resulting from decompression sickness: MR findings in a case and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8584297" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Paraplegia and decompression sickness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8584297" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Paraplegia and decompression sickness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8584297" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Paraplegia and decompression sickness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3801847" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : Studies on the aetiology and pathogenesis of motor neuron diseases. 1. Lathyrism: clinical findings in established cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11801419" id="rid146" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          147 : Abnormalities of somatosensory evoked potentials in konzo--an upper motor neuron disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11870691" id="rid147" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          148 : Analysis of motor pathway involvement in konzo using transcranial electrical and magnetic stimulation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8204366" id="rid148" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          149 : Symptoms and signs in metastatic spinal cord compression: a study of progression from first symptom until diagnosis in 153 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10725627" id="rid149" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          150 : Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15796348" id="rid150" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          151 : Intramedullary spinal cord tumors in patients older than 50 years of age: management and outcome analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20212227" id="rid151" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          152 : Myelopathies in patients with cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10494534" id="rid152" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          153 : MR imaging of neoplasms of the lumbar spine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9851643" id="rid153" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          154 : Diagnosis of amyotrophic lateral sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9851643" id="rid154" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          155 : Diagnosis of amyotrophic lateral sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9851643" id="rid155" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          156 : Diagnosis of amyotrophic lateral sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12707427" id="rid156" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          157 : Primary lateral sclerosis: A heterogeneous disorder composed of different subtypes?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9365366" id="rid157" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          158 : Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8813280" id="rid158" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          159 : Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8813280" id="rid159" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          160 : Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10869061" id="rid160" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          161 : Preserved slow conducting corticomotoneuronal projections in amyotrophic lateral sclerosis with autosomal recessive D90A CuZn-superoxide dismutase mutation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19007737" id="rid161" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          162 : Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12432827" id="rid162" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          163 : Hereditary spastic paraplegia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16469273" id="rid163" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          164 : Hereditary spastic paraplegia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15498485" id="rid164" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          165 : Neuropathology: many paths lead to hereditary spastic paraplegia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12512341" id="rid165" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          166 : Hereditary spastic paraplegia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12849205" id="rid166" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          167 : Many pathways lead to hereditary spastic paraplegia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18332254" id="rid167" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          168 : Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15, and further genetic heterogeneity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17342190" id="rid168" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          169 : X-linked adrenoleukodystrophy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/200861" id="rid169" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          170 : Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8815938" id="rid170" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          171 : Clinical and genetic abnormalities in patients with Friedreich's ataxia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16344344" id="rid171" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          172 : Late-onset Friedreich ataxia: phenotypic analysis, magnetic resonance imaging findings, and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16676921" id="rid172" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          173 : Classification of syringomyelia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16549414" id="rid173" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          174 : Ethnic differences in syringomyelia in New Zealand.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11807404" id="rid174" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          175 : Concurrent syrinx and inflammatory central nervous system disease detected by magnetic resonance imaging: an illustrative case and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16506486" id="rid175" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          176 : Cordectomy for the treatment of posttraumatic syringomyelia. Report of four cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16676930" id="rid176" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          177 : Primary spinal syringomyelia: a personal perspective.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16676923" id="rid177" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          178 : Pain and syringomyelia: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14621236" id="rid178" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          179 : Cervical spondylotic myelopathy: make the difficult diagnosis, then refer for surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17204884" id="rid179" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          180 : Cervical spondylotic myelopathy: a brief review of its pathophysiology, clinical course, and diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22164324" id="rid180" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          181 : Ossification of the posterior longitudinal ligament: a review of literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19278325" id="rid181" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          182 : Cervical myelopathy in patients with ossification of the posterior longitudinal ligament.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22146284" id="rid182" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          183 : Ossification of the posterior longitudinal ligament of the cervical spine: etiology and natural history.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21434817" id="rid183" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          184 : Ossification of the posterior longitudinal ligament: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22914701" id="rid184" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          185 : Analysis of demographics, clinical, and radiographical findings of ossification of posterior longitudinal ligament of the cervical spine in 146 Korean patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25811134" id="rid185" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          186 : Ossification of the posterior longitudinal ligament of the cervical spine in 3161 patients: a CT-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21857407" id="rid186" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          187 : Risk factors for acute cervical spinal cord injury associated with ossification of the posterior longitudinal ligament.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23152585" id="rid187" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          188 : Surfers' myelopathy: a case series of 19 novice surfers with nontraumatic myelopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21765307" id="rid188" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          189 : Surfer's myelopathy-demonstrated by diffusion-weighted magnetic resonance imaging: a case report and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22257974" id="rid189" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          190 : Complete paraplegia resulting from surfer's myelopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22544059" id="rid190" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          191 : An Australian case of surfer's myelopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21196015" id="rid191" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          192 : Non-traumatic anterior spinal cord infarction in a novice surfer: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20963461" id="rid192" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          193 : Surfer's myelopathy--an unusual cause of acute spinal cord ischemia: a case report and review of the literature.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
